Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 22.22
-0.20 (-0.89%)
At close: Jul 30, 2025, 2:57 PM CST
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 8.06 billion as of August 1, 2025. Its market cap has increased by 292.88% in one year.
Market Cap
8.06B
Enterprise Value
7.70B
Revenue
133.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.22
Market Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 8.06B, a decrease of -25.05%. That is a compound annual growth rate of -5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 8.06B | 120.59% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | 6.93B | -35.64% |
| Oct 28, 2020 | 10.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 424.16B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| WuXi AppTec | 282.77B |
| Sichuan Biokin Pharmaceutical | 130.49B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.22B |
| Aier Eye Hospital Group | 122.33B |
| Shanghai United Imaging Healthcare | 112.35B |
| Yunnan Baiyao Group Co.,Ltd | 102.45B |